Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review.

Authors

  • Sushil Kumar Assistant Professor, Department of Biochemistry, Rama Medical College, Kanpur.
  • Parvez Saeed Ansari Associate Professor, Department of General Medicine, Dr B.S. Kushwah Institute of Medical Sciences, A/1-8, Lakhanpur, Kanpur-208024 (Uttar Pradesh),
  • Shraddha Singh Associate Professor, Department of Biochemistry, People College of Medical Science and Research Center, Bhopal,

Abstract

Background: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities associated with an increased risk of type 2 diabetes mellitus and cardiovascular diseases. Serum ferritin, an indicator of iron stores and inflammation, has been suggested as a potential biomarker of metabolic dysfunction.

Objective: To evaluate the association of serum ferritin with metabolic syndrome, insulin resistance, dyslipidaemia, and abdominal obesity.

Materials and Methods: A systematic review was conducted following PRISMA guidelines. Literature was searched through PubMed, Google Scholar, Scopus, and ScienceDirect. Original human observational studies published in English were considered. Studies investigating serum ferritin in relation to metabolic syndrome, HOMA-IR, glycaemic parameters, lipid profile, BMI, and abdominal obesity were included. Relevant study characteristics and major findings were extracted and analysed descriptively.

Results: The reviewed studies demonstrated a positive association between serum ferritin and metabolic syndrome, insulin resistance, fasting blood glucose, fasting insulin, triglycerides, BMI, waist circumference, and waist-to-hip ratio. Kumar et al. (2026) reported a significant correlation between ferritin and metabolic syndrome severity (r=0.62, p=0.001). Chand et al. (2021) observed positive correlations with HOMA-IR, BMI, waist-to-hip ratio, and triglycerides, along with a negative correlation with HDL cholesterol. Associations with LDL cholesterol, total cholesterol, and blood pressure were inconsistent.

Conclusion: Elevated serum ferritin is associated with metabolic syndrome and its major components, particularly insulin resistance, hypertriglyceridaemia, and abdominal obesity. Serum ferritin may serve as an additional biomarker for identifying individuals at increased cardiometabolic risk. Further prospective studies are required to establish its clinical significance.

Keywords:

Serum ferritin, metabolic syndrome, insulin resistance, dyslipidaemia, abdominal obesity, HOMA-IR

DOI

https://doi.org/10.37022/wjcmpr.v8i3.477

References

1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.

2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.

3. Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474-89.

4. Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr RelatDisord. 2009;7(6):497-514.

5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.

6. Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care. 2007;30(7):1926-33.

7. Chand MR, Agarwal N, Nishanth D, Sankar J. Association of serum ferritin levels with metabolic syndrome in India: a cross-sectional study. Maedica (Bucur). 2021;16(1):48-53.

8. Srivastav SK, Mir IA, Bansal N, Singh PK, Kumari R, Deshmukh A. Serum ferritin in metabolic syndrome: mechanisms and clinical applications. Pathophysiology. 2022;29(2):319-25.

9. Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, et al. Consensus statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol. 2023;19(5):299-310.

10. Zhang W, et al. Serum ferritin and the risk of metabolic syndrome: a systematic review and dose-response meta-analysis of cross-sectional studies. Biomed Environ Sci. 2021;34(8):623-31.

11. Vigneshvar T, Karnam AHF, Manju M. Serum ferritin as a biomarker for diagnosis of metabolic syndrome: a cross-sectional study. J Chem Health Risks. 2024.

12. Bhadana N, Agarwal R, Bansal S, Kumar A. Association of serum ferritin levels with metabolic syndrome: a cross-sectional study. Ann Afr Med. 2025.

13. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care. 2004;27(10):2422-8.

14. Hitha H, Gowda D, Mirajkar A. Serum ferritin level as an early indicator of metabolic dysregulation in young obese adults: a cross-sectional study. Can J Physiol Pharmacol. 2018;96(12):1255-60.

15. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults. Diabetes Care. 1999;22(12):1978-83.

16. Wrede CE, Buettner R, Bollheimer LC, Schölmerich J, Palitzsch KD, Hellerbrand C. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol. 2006;154(2):333-40.

17. Vigneshvar T, Karnam AHF, Manju M. Serum ferritin as a biomarker for diagnosis of metabolic syndrome: a cross-sectional study. J Chem Health Risks. 2024;14(6):1616-22.

18. Bhadana N, Agarwal R, Bansal S, Kumar A. Association of serum ferritin levels with metabolic syndrome: a cross-sectional study. Ann Afr Med. 2025. doi:10.4103/aam.aam_551_25.

Published

2026-11-22
Statistics
Abstract Display: 0
PDF Downloads: 0
Dimension Badge

How to Cite

1.
Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review. World Journal of Current Med and Pharm Research [Internet]. 2026 Nov. 22 [cited 2026 Nov. 22];8(3):318-22. Available from: https://wjcmpr.org/index.php/journal/article/view/477

Issue

Section

Research Articles

How to Cite

1.
Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review. World Journal of Current Med and Pharm Research [Internet]. 2026 Nov. 22 [cited 2026 Nov. 22];8(3):318-22. Available from: https://wjcmpr.org/index.php/journal/article/view/477